{
  "abstract": "Purpose: To evaluate the early safety and technical feasibility of Amber 20 for peripheral vascular embolization in a prospective, multicenter, first-in-human stage I study.\n\nMaterials and methods: This was a prospective, single-arm, multicenter, open-label first-in-human stage I trial conducted across 11 centers in Spain. Fifteen patients requiring peripheral embolization for various indications (including hemorrhage, aneurysm/pseudoaneurysm, endoleak, portal vein embolization, and hypervascular tumors) were enrolled. The primary endpoint was the rate of device-related serious adverse events (SAEs) within 24 h. Secondary endpoints included overall adverse events (AEs) and technical success, defined as complete vascular occlusion or devascularization on final angiography.\n\nResults: Fifteen patients (60% female; median age 56 years) underwent embolization using Amber 20. Technical success was achieved in 100% of cases (15/15). No device-related SAEs or AEs were reported within 24 h. Five patient (33%) experienced a mild adverse event (postembolization syndrome) related to the procedure. All adverse events resolved without sequelae. No device deficiencies were observed.\n\nConclusion: In this first-in-human, multicenter study, Amber 20 demonstrated a favorable safety profile and high technical success rate for peripheral vascular embolization. These preliminary findings support its potential as an effective liquid embolic agent, warranting further evaluation in larger studies with longer follow-up (stage II).\n\nGraphical Abstract:",
  "abstract_shown": true,
  "affiliations": [
    "Department of Interventional Radiology, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain",
    "Department of Interventional Radiology, Hospital Ramón y Cajal, Madrid, Spain",
    "Department of Interventional Radiology, Hospital General Universitario Dr Balmis, Alicante, Spain",
    "Department of Interventional Radiology, Hospital Universitari Vall d’Hebron, Barcelona, Spain",
    "Department of Interventional Radiology, Hospital Universitario de Navarra, Pamplona, Barcelona, Spain",
    "Department of Interventional Radiology, Hospital Universitari I Politècnic La Fe Hospital, Valencia, Spain",
    "Department of Interventional Radiology, Hospital Clinic de Barcelona, Barcelona, Spain",
    "Department of Interventional Radiology, Hospital Universitari I Politècnic La Fe Hospital, Data Manager, Valencia, Spain",
    "Department of Interventional Radiology, Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain",
    "Department of Interventional Radiology, Hospital Lozano Blesa, Saragossa, Spain",
    "Department of Interventional Radiology, Interventional Nursing, Hospital Universitari I Politècnic La Fe Hospital, Valencia, Spain",
    "Department of Interventional Radiology, Hospital Universitario Reina Sofía, Córdoba, Spain",
    "Department of Interventional Radiology, Hospital Ribera Povisa, Vigo, Spain",
    "iVascular S.L.U., Sant Vicenç Dels Horts, Barcelona, Spain"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 23,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Elena Serrano"
    },
    {
      "affs": [
        1
      ],
      "name": "José Urbano"
    },
    {
      "affs": [
        2
      ],
      "name": "Javier Irurzun"
    },
    {
      "affs": [
        3
      ],
      "name": "Mercedes Pérez"
    },
    {
      "affs": [
        4
      ],
      "name": "Iñigo Insausti"
    },
    {
      "affs": [
        5
      ],
      "name": "Raúl García"
    },
    {
      "affs": [
        6
      ],
      "name": "Arantxa Gelabert"
    },
    {
      "affs": [
        7
      ],
      "name": "Serena Pisoni"
    },
    {
      "affs": [
        8
      ],
      "name": "Roberto Correa"
    },
    {
      "affs": [
        9
      ],
      "name": "Andrés Guirola"
    },
    {
      "affs": [
        10
      ],
      "name": "Miguel Cibrán"
    },
    {
      "affs": [
        11
      ],
      "name": "Juanjo Espejo"
    },
    {
      "affs": [
        12
      ],
      "name": "Mariano Magallanes"
    },
    {
      "affs": [
        13
      ],
      "name": "Sara Pich"
    },
    {
      "affs": [
        13
      ],
      "name": "Aina Fernández"
    },
    {
      "affs": [
        13
      ],
      "name": "Sofia Valle"
    },
    {
      "affs": [
        13
      ],
      "name": "Álex Gómez"
    },
    {
      "affs": [
        13
      ],
      "name": "María Molina"
    },
    {
      "affs": [
        0
      ],
      "name": "Antonio López-Rueda"
    },
    {
      "affs": [
        5
      ],
      "name": "Jose Joaquín Martínez"
    },
    {
      "affs": [
        13
      ],
      "name": "Lluis Duocastella"
    },
    {
      "affs": [
        5
      ],
      "name": "Fernando M. Gómez",
      "orcid": "0000-0003-0944-9819"
    },
    {
      "name": "research team of the OPAL study"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7c3f6z0skadrm.bib",
  "cited_by": 0,
  "doi": "10.1186/s42155-026-00797-2",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13755156/",
  "id": "7c3f6z0skadrm",
  "issns": [
    "2520-8934"
  ],
  "landing_url": "https://doi.org/10.1186/s42155-026-00797-2",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "New Technologies"
    ],
    [
      "openalex",
      "2716|Vascular Anomalies and Treatments"
    ]
  ],
  "openalex": "W7212002868",
  "pdf_url": "https://link.springer.com/content/pdf/10.1186/s42155-026-00797-2.pdf",
  "pmcid": "PMC13755156",
  "pmid": "43013176",
  "published": "2026-11-11",
  "publisher": "Springer",
  "ris": "https://research.draconitic.com/paper/7c3f6z0skadrm.ris",
  "sources": [
    {
      "first_seen": "2026-11-15T12:24:01Z",
      "native_id": "PMC13755156",
      "source": "pmc",
      "url": "https://doi.org/10.1186/s42155-026-00797-2"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2716|Vascular Anomalies and Treatments",
      "subfield": "human-genetics"
    }
  ],
  "title": "Feasibility, safety, and efficacy of the amber peripheral liquid embolic system: results from stage I of the first-in-human OPAL study",
  "title_text": "Feasibility, safety, and efficacy of the amber peripheral liquid embolic system: results from stage I of the first-in-human OPAL study",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:21:17Z",
  "url": "https://research.draconitic.com/paper/7c3f6z0skadrm",
  "venue": "CVIR Endovascular",
  "versions": []
}